Dec 11 (Reuters) - The U.S. Food and Drug Administration has approved Flow Neuroscience's at-home brain stimulation device to treat depression, offering an alternative to typical antidepressants that ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Alex Morrell Every time Alex publishes a story, you’ll get an alert straight to your inbox!

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

James Chen, CMT is an expert trader, investment adviser, and global market strategist. Gordon Scott has been an active investor and technical analyst or 20+ years. He is a Chartered Market Technician ...

Flow chemistry is the development and study of chemical reactions whereby reactants are combined by pumping fluids, including solutions of reagents, through tubes at known rates. The relative ...

How did long term mutual funds and ETFs perform last month? Understand the short-term and long-term trends affecting equity funds, sector-equity funds, bond-funds, and more. Each month, Morningstar ...

Global sustainable funds faced net outflows of approximately USD 55 billion in Q3 2025, a sharp reversal from the USD 5.8 billion inflows in the previous quarter. This shift was driven primarily by ...

Note: All Broadway Box Office data is presented for informational purposes only. BroadwayWorld makes no guarantees as to the accuracy of the data, or the matter in which it's presented. Source: The ...

Russian billionaire Potanin acquires minority stake in cloud provider Selectel A joint venture controlled by Russian billionaire Vladimir Potanin has acquired a 25% stake in IT infrastructure provider ...

The OSE Benchmark stock price has ranged from 1,314.60 to 1,670.25 over the past 52 weeks. The opening price for OSE Benchmark today was 1,662.43.